Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
AUTOR(ES)
Larsen, Claus M.
FONTE
American Diabetes Association
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2732140Documentos Relacionados
- The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
- Physiologic role of interleukin-1 receptor antagonist
- Interleukin-1 Receptor Antagonist Gene Polymorphism, Vaginal Interleukin-1 Receptor Antagonist Concentrations, and Vaginal Ureaplasma urealyticum Colonization in Pregnant Women
- Effects of Interleukin-1 Receptor Antagonist Overexpression on Infection by Listeria monocytogenes
- Interleukin-1 receptor antagonist in normal and psoriatic epidermis.